MEN1 Syndrome with Pancreatic Involvement and Synchronous Lung Adenocarcinoma: A Case Report Abstract #1509

Introduction: Lung lesions in MEN1 patients makes us consider firstly a neuroendocrine tumor (NET) as carcinoids are part of MEN1 syndrome.
Aim(s): To report the clinical and pathological features of a patient with synchronous MEN1 syndrome with both pulmonary carcinoid and adenocarcinoma.
Materials and methods: A 66 years old male, belonging a MEN 1 family and with previous antrectomy for duodenal ulcer, was observed for persistent epigastric pain. Laboratory findings were consistent with Zollinger-Ellison syndrome and hyperparathyroidism. CEA was slightly elevated. Abdominal CT-scan showed a 6 cm hypervascular mass in the body of the pancreas positive to Octreoscan scintigraphy, while FDG-PET demonstrated hypermetabolism in the pancreas and the right lung in an area of 2.6 cm confirmed by thoracic MRI, with mediastinal pleura involvement. The patient underwent a right superior lobectomy. Histology reported acinar adenocarcinoma (T3N1G3) coexisting with 1 cm carcinoid with one positive lymphnode. Three months later he underwent a spleen-distal pancreatectomy, subtotal parathyroidectomy and duodenal tumor excision.
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: Doctor Valbona Liço
Keywords: men1

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1093 38 Years of Experience in a Single Centre on Neuroendocrine Pancreatico-Duodenal Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome
Introduction: Multiple Endocrine Neoplasia type 1 (MEN1) syndrome has an autosomal dominant transmission. Combination of tumors: parathyroid, pituitary and pancreatico-duodenal (PD) NETs. PD NETs in MEN1 syndrome show propensity for malignant degeneration.
Conference: 12th Annual ENETS Conference (2015)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Doctor Valbona Lico
#1482 Duodenum Preserving Pancreatic Head Resection for Neuroendocrine Pancreatic Tumors of the Head of the Pancreas.
Introduction: Duodenum Preserving Pancreatic Head Resection (DPPHR) is a surgical procedure uncommonly used in benign tumors of the head of the pancreas as alternative to pancreaticoduodenectomy.
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: Doctor Valbona Liço
Keywords: dpphr
#1236 Management and Clinical Outcome of Patients with MEN 1 Disease Presenting Non Functioning Pancreatic Neuroendocrine Neoplasms (NF-pNEN) ≤ 2 cm
Introduction: The role of surgery for NF-pNEN ≤ 2 cm in MEN1 patients is still controversial.
Conference: 12th Annual ENETS Conference (2015)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Domenico Tamburrino
#1438 An Unusual Phenotype of Multiple Endocrine Neoplasia Type 1 with a Small Intestine Neuroendocrine Tumor Associated with Large Deletion of the MEN1 Gene
Introduction: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant inherited tumor syndrome that is caused by germline mutations in the Menin suppressor gene on chromosome 11q13. Small intestine neuroendocrine neoplasias (SI-NEN) are currently not considered to be part of the phenotype of the MEN1-syndrome.
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: MD Jerena Manoharan
#1769 Minimal Risk of Persistent or Recurrent Hypoglycemia after MEN1-Related Insulinoma Surgery. A Large International Cohort Study
Introduction: Current literature states that 15-30% of the MEN1 patients suffer from hypoglycemia after insulinoma surgery.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Drs. Sjoerd Nell
Keywords: MEN1